Adamis Pharmaceuticals Co...

NASDAQ: ADMP · Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM

Adamis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.08M 23.22M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
52.17K 109.14K
Receivables
1.09M 5.9M
Inventory
1.24M 418.61K
Other Current Assets
893.93K 215.3K
Total Current Assets
9.27M 35.2M
Property-Plant & Equipment
1.61M 2.99M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
1.66M 3.09M
Total Assets
10.93M 38.3M
Account Payables
7.94M 3.75M
Deferred Revenue
27.78K 100K
Short-Term Debt
342.56K 349.87K
Other Current Liabilities
3.09M 7.02M
Total Current Liabilities
11.4M 11.22M
Long-Term Debt
n/a 342.56K
Other Long-Term Liabilities
164.79K 99.66K
Total Long-Term Liabilities
343.04K 1.19M
Total Liabilities
11.74M 12.42M
Total Debt
342.56K 692.43K
Common Stock
15.05K 15.01K
Retained Earnings
-304.56M -278.09M
Comprehensive Income
n/a n/a
Shareholders Equity
-808.07K 25.88M
Total Investments
n/a n/a